Thyrocare Technologies hits 52-week high, surges 28% in two days

The company's normalized Ebitda grew 19 per cent year on year (YoY) at Rs 42.5 crore, while margins improved to 40 per cent compared with 37 per cent clocked in the previous year quarter

Shares of Thyrocare Technologies surged 14 per cent to Rs 689 on the BSE on Tuesday after the company reported a strong operational performance with consolidated earnings before interest, tax, depreciation and amortisation (Ebitda) expanding by 300 basis points in the December quarter (Q3FY20).

The stock of the healthcare services company was quoting at its 52-week high level. Besides, it has zoomed 28 per cent in the past two trading days, as compared to a 2 per cent rise in the S&P BSE Sensex.

The company’s normalized Ebitda grew 19 per cent year on year (YoY) at Rs 42.5 crore, while margins